Document is current
Any future updates will be listed below
-
Authors
Al-Karagholi, Mohammad Al-Mahdi
Zhuang, Zixuan Alice
Beich, Signe
Ashina, Håkan
Ashina, Messoud
-
Funding
Funding for this research was provided by:
H. Lundbeck A/S (IIT-2022-007)
- License Information
-
More Information
Article History
Received: 28 December 2024
Accepted: 1 April 2025
First Online: 14 April 2025
Declarations
:
: The study protocol was reviewed and approved by the Regional Health Research Ethics Committee of the Capital Region of Denmark (identifier: H-22038923). All participants provided written informed consent before enrollment, ensuring that they were fully informed about the study procedures and potential risks.
: Not applicable.
: M.A. has received personal fees from AbbVie, Amgen, AstraZeneca, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Pfizer, and Teva Pharmaceuticals for consulting, advisory board participation, and speaker honoraria, outside of the submitted work. M.A. also serves as an Associate Editor of Brain and The Journal of Headache and Pain. H.A. has received personal fees from AbbVie, Lundbeck, Pfizer, and Teva for consulting, advisory board participation, and speaker honoraria, outside of the submitted work. The remaining authors declare no competing interests.
